Stoke Therapeutics Appoints Ian Smith to its Board of Direct

– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases –

...

Related Keywords

Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , Bedford , Edwardm Kaye , Ian Smith , Ianf Smith , Viacyte Inc , Stoke Therapeutics Inc , Manchester Metropolitan University United Kingdom , Augmentation Of Nuclear Gene Output , Senior Advisor To Bain Capital Life Sciences , Vexsol Inc , Nasdaq , Alkeus Pharmaceuticals , Vertex Pharmaceuticals , Stoke Therapeutics , Chief Executive Officer , Senior Advisor , Bain Capital Life Sciences , Executive Chair , Solid Biosciences , Foghorn Therapeutics , Executive Vice President , Chief Operating Officer , Chief Financial Officer , Manchester Metropolitan University , Targeted Augmentation , Nuclear Gene Output , Markets ,